Khiron Life Sciences Corp.
|
|||
| Mailing Address: | c/o Gowling WLG (Canada) LLP 100 King St.W., Suite 1600 1 First Canadian Place Toronto, Ontario M5X 1G5 |
Head Office Address: | Gowling WLG (Canada) LLP 2300 - 500 Burrard Street Vancouver, BC V6C 2B5 |
| Contact Name: | Darren Collins | Principal Regulator: | British Columbia |
| Business e-mail address: | dcollins@Khiron.ca | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 705 527-3564 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland |
| Fax Number: | Stock Exchange: | TSX Venture | |
| Date of Formation: | May 16 2012 | Stock Symbol: | KHRN |
| Jurisdiction Where Formed: | BC | Auditor: | MNP LLP |
| Industry Classification: | other | General Partner: | |
| CUSIP Number: | 49374L | Transfer Agent: | TSX Trust Company |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
